1. Introduction {#sec1-microorganisms-08-01158}
===============

The outbreak with the new coronavirus (COVID-19) caused by severe acute respiratory syndrome (SARS-CoV-2) has led to a 'global pandemic' due to its unprecedented speed of spreading worldwide. Since patient zero that was reported back in mid-November, over ten million people from two hundred and sixteen territories were identified as SARS-CoV-2-infected patients \[[@B1-microorganisms-08-01158]\].

Significant discoveries have been made in this context during these last nine months. During this period, the clinical panel has been established \[[@B2-microorganisms-08-01158],[@B3-microorganisms-08-01158],[@B4-microorganisms-08-01158],[@B5-microorganisms-08-01158],[@B6-microorganisms-08-01158],[@B7-microorganisms-08-01158],[@B8-microorganisms-08-01158],[@B9-microorganisms-08-01158]\]. However, the early studies have also revealed a low \[[@B3-microorganisms-08-01158],[@B4-microorganisms-08-01158],[@B5-microorganisms-08-01158],[@B10-microorganisms-08-01158]\], up to medium \[[@B6-microorganisms-08-01158],[@B7-microorganisms-08-01158],[@B8-microorganisms-08-01158],[@B9-microorganisms-08-01158]\] incidence of gastrointestinal deficiencies. The most common symptom was diarrhea \[[@B11-microorganisms-08-01158],[@B12-microorganisms-08-01158],[@B13-microorganisms-08-01158],[@B14-microorganisms-08-01158]\], which suggests a potential route of action of COVID-19 at the level of the digestive tract.

Unfortunately, until the 10th of July 2020, more than half a million people have died, predisposition being higher in people suffering from chronic diseases and, especially elderly \[[@B15-microorganisms-08-01158]\]. However, the number of people confirmed positive varies due to finite capacities in epidemiological surveillance between countries.

It can be said without a shadow of a doubt, that this member of the zoonotic coronavirus family has spread over the entire world until the present day. Given that scientists are in a fight against the clock, the need for a sustainable and reliable strategy for planning health infrastructure to control the spread is crucial. This need is all the more imperative as there is no SARS-CoV-2 treatment/vaccine \[[@B15-microorganisms-08-01158]\].

Modeling daily cases are pivotal for management and future directions. Estimating COVID-19 possible evolution or regression through mathematical and statistical models is groundbreaking to determine short and long-term case estimates. Such approaches are viable not only to predict the COVID-19 spreading course, but also to allocate the resources necessary to restrict the virus spreading \[[@B15-microorganisms-08-01158]\].

Distinct approaches have been applied with relatively high accuracy for different prediction purposes. Some examples are represented by statistical methods aiming to predict epidemic cases. These include time series \[[@B16-microorganisms-08-01158]\], or simulation models \[[@B17-microorganisms-08-01158],[@B18-microorganisms-08-01158]\], multivariate linear regression \[[@B19-microorganisms-08-01158]\], backpropagation neural network \[[@B20-microorganisms-08-01158],[@B21-microorganisms-08-01158],[@B22-microorganisms-08-01158]\], and gray forecasting \[[@B23-microorganisms-08-01158],[@B24-microorganisms-08-01158]\].

Any epidemiology evolution is defined and influenced by different factors, more precisely by a tendency of randomness. Retrospectively, the usage of the statistics tools above-mentioned are insufficient for analysis and are difficult to generalize. This is why the Automatic Regressive Integrated Moving Average (ARIMA) model has been successfully applied at a much larger scale in various fields, mainly due to its easy-to-use concept and utility algorithm \[[@B25-microorganisms-08-01158]\].

Therefore, the present study aims to estimate the prevalence trend in Ukraine, Romania, the Republic of Moldova, Serbia, Bulgaria, and Hungary as Central European countries. Moreover, we will also consider the most affected countries presently, such as USA, Brazil, and India.

2. Materials and Methods {#sec2-microorganisms-08-01158}
========================

2.1. Data {#sec2dot1-microorganisms-08-01158}
---------

The daily prevalence data of COVID-19 was taken from The Ministry of Internal Affairs of Romania (<https://www.mai.gov.ro/informare-covid-19-grupul-de-comunicare-strategica>), World Health Organization (WHO) (<https://covid19.who.int/?gclid=CjwKCAjwi_b3BRAGEiwAemPNUYzgrAMkQXN5Z848tjCmGZLJecod03yWxqW_bN248wjgdezXeYg0RoCeFcQAvD_BwE>), and European Centre for Disease Prevention and Control (ECDC) (<https://www.ecdc.europa.eu/en>). MS Excel was used to build a time-series database. Descriptive statistics of the COVID-19 data for the established intervals (10 March and 10 July) are given in [Table 1](#microorganisms-08-01158-t001){ref-type="table"}. In order to create an optimum ARIMA model, at least 30 observations are needed \[[@B26-microorganisms-08-01158]\].

Data analyzed corresponds to the period between 10 March and 10 July. The data set was used to perform and analyze a case estimation model by applying ARIMA that could help us to predict the SARS-CoV-2 evolution in the future.

Therefore, for this study, a time series containing at least 45 data was used to predict COVID-19 prevalence in six Central and Eastern European countries (Romania, Bulgaria, Serbia, Ukraine, Republic of Moldova, and Hungary) was conducted. Furthermore, the same concept was applied for one country from South America (Brazil) and North America (United States of America), and one from South Asia (India) over the next fourteen days with 95% relative confidence intervals (CI).

As seen from [Figure 1](#microorganisms-08-01158-f001){ref-type="fig"}, the COVID-19 outbreak hit Ukraine harder than the other five countries between the established period. The first case in Ukraine was reported on 3 March 2020. In contrast with the related regions, the COVID-19 pandemic had started earlier in Romania (26 February) and later in the other four (4 March in Hungary, 6 March in Serbia, 7 March in the Republic of Moldova, and 8 March in Bulgaria). In Ukraine, the total number of confirmed cases of COVID-19 reported during the period is 52,043, the highest number of new cases reported being 1366 registered on 6 July.

The overall prevalence for Romania was 31,381, the second hardest-hit region, followed by the Republic of Moldova with 18,666, Serbia with 17,342, Bulgaria with 6672, and Hungary with 4220 cases. Analogous, the second highest incidence between the remaining five regions was in Romania with 614 new cases in 9 July, followed by the Republic of Moldova with 478 on 18 June, 445 in Serbia on 17 April, 330 in Bulgaria on 10 July, and 210 in Hungary on 10 April.

On the other hand, the first case reported in the USA took place on 20 January, almost one week later compared with Romania. The second hardest-hit region was Brazil, where the first case was reported on 26 February, while in India on 30 January. The overall prevalence for these three countries is as follows: USA with 3,038,325, Brazil with 1,713,160, and India with 793,892 cases. Concerning the incidence, the highest was as expected in USA with 64,630 on 10 July, followed by Brazil with 54,771 on 21 June, and last, India with 26,506 on 10 July.

2.2. ARIMA Models {#sec2dot2-microorganisms-08-01158}
-----------------

A time series is simply a series of time-dependent data points \[[@B27-microorganisms-08-01158]\] used for analyses dedicated to revealing reliable and meaningful statistical data for the subsequent prediction of values of a series \[[@B28-microorganisms-08-01158]\]. Since it was introduced by Box and Jenkins approximately half a century ago, ARIMA began to be used at a much larger scale \[[@B26-microorganisms-08-01158]\].

In most cases, ARIMA is used since it takes into account all trends and periodic changes, even random disturbances. Thus, ARIMA is suitable for a large spectrum of data, from seasonality to cyclicity. In this context can be modeled a temporal dependency in a flexible manner.

Non-seasonal ARIMA models are defined by three parameters (*p*, *d*, *q*) where *p* is the order of autoregression, *d* is the degree of differencing, and *q* the order of moving average \[[@B29-microorganisms-08-01158]\]. ARIMA offers the possibility to be modified so that can be conducted different and simple AR, I, or MA models.

AR (p) usually explains the present value Y~t,~ unidirectionally it terms of its previous values Y~t−1~, Y~t−2~, \..., Y~t−p~, and the current residuals ε~t~. MA (q) refers to the current value of the time series Y~t~ in terms of its current and previous residuals ε~t−1~, ε~t−2~,..., ε~t−𝑞~. The general formula of AR (p) and MA (q) can be expressed in Equations (1) and (2). where:

p---past value;

Φ and θ---parameters that indicate the autoregression, and moving average, respectively;

t---time;

Y~t~---observed value at a time t;

ε~t~---value of the random shock dependent by t;

p---past value.

In other words, ARMA (p, q) model expresses the current values, as well as its previous ones and residuals linearly. The corresponding formula is given in the below equation: where:

α---constant;

ε~t−1~---value of the previous random shock.

2.3. Model Selection {#sec2dot3-microorganisms-08-01158}
--------------------

In the present study, three performance criteria entitled Root Mean Square Error (RMSE), Mean Absolute Error (MAE), and Mean Absolute Percentage Error (MAPE) were applied to test the predictive accuracy of the current ARIMA model. Mathematically, the equations for these three criteria are presented above:$$RMSE = \sqrt{\frac{1}{n}}\sum\limits_{t = 1}^{n}e_{t}^{2}$$ $$MAE = \frac{1}{n}\sum\limits_{t = 1}^{n}\left| e_{t} \right|$$ $$MAPE = \frac{100\%}{n}\sum\limits_{i = 1}^{n}\left| \frac{e_{t}}{y_{t}} \right|$$ where:

y~t~---value observed at a time t;

e~t~---difference between values;

n---number of time points;

For a better fit of the data, RMSE, MAE, and MAPE must have low values. All analyses were performed using STATGRAPHICS Centurion (v.18.1.13) software with a statistically significant level of *p* \< 0.005.

3. Results and Discussion {#sec3-microorganisms-08-01158}
=========================

Forecasting the Prevalence of COVID-19 Pandemic Using the ARIMA Model
---------------------------------------------------------------------

The ARIMA modeling is composed of four repetitive steps: assessment of the model, estimation of parameters, diagnostic checking, and prediction. The first step is to control whether the time series' mean, variance, and autocorrelation constancy over time are stationary and seasonal for a better accuracy \[[@B30-microorganisms-08-01158]\]. In this context, Time Series plot, Autocorrelation Function (ACF), and Partial Autocorrelation Function (PACF) ([Figure 2](#microorganisms-08-01158-f002){ref-type="fig"}) graphs were constructed to verify the seasonality and stationarity. On one hand, ACF can determine whether the previous values from the series are related to the following one, while PACF highlights the degree of correlation between a variable and a lag of the said variable \[[@B31-microorganisms-08-01158]\]. Estimated autocorrelations for the time series of the established countries are shown in [Figure 3](#microorganisms-08-01158-f003){ref-type="fig"}. Straight lines represent two standard deviations limits, while bars that extend beyond the lines indicate statistically significant autocorrelations.

Additionally, a series of ARIMA models have been also created, and their performances were compared using various statistical tools. All statistical procedures were performed on the transformed COVID-19 data. ARIMA models with the minimum MAPE values were selected as the best model. Among the tested models, the ARIMA (1, 1, 0), ARIMA (3, 2, 2), ARIMA (3, 2, 2), ARIMA (3, 1, 1), ARIMA (1, 0, 3), ARIMA (1, 2, 0), ARIMA (1, 1, 0), ARIMA (0, 2, 1), and ARIMA (0, 2, 0) models were chosen as the best models for Ukraine, Romania, the Republic of Moldova, Serbia, Bulgaria, Hungary, USA, Brazil, and India. The models fitted the COVID-19 data are presented in [Figure 2](#microorganisms-08-01158-f002){ref-type="fig"} and [Table 2](#microorganisms-08-01158-t002){ref-type="table"} and [Table 3](#microorganisms-08-01158-t003){ref-type="table"} with a minimum *MAPE~Ukraine~* = 4.70244, *MAPE~Romania~* = 1.40016, *MAPE~Republic\ of\ Moldova~* = 2.76751, *MAPE~Serbia~* = 2.16733, *MAPE~Bulgaria~* = 2.98154, *MAPE~Hungary~* = 2.11239, *MAPE~USA~* = 3.21569, *MAPE~Brazil~* = 4.10596, *MAPE~India~* = 2.78051.

[Table 3](#microorganisms-08-01158-t003){ref-type="table"} shows the parameter estimates for the best models. The *p*-values of the associated with the parameters are less than 0.005, so the terms are considerably different from zero at the 95.0% CI. The fitted and predicted values are presented in [Figure 3](#microorganisms-08-01158-f003){ref-type="fig"}. As seen in [Table 4](#microorganisms-08-01158-t004){ref-type="table"}, the next 14-day estimate of confirmed cases may be between 52,816--59,679 in Ukraine, 31,838--38,650 in Romania, and 18,836--21,601 in the Republic of Moldova, 17,639--21,313 in Serbia, 6931--10,000 in Bulgaria, 4225--4319 in Hungary, 3.10259 × 10^6^--3.90611 × 10^6^ in USA, 1.75087 × 10^6^--2.24113 × 10^6^ in Brazil, and 8.20308 × 10^5^--116,489 × 10^6^ in India, respectively.

In the present study, an ARIMA model has been selected, in which the best model forecast for future data is given by a parametric model relating the most recent data value to previous data values and previous noise, or residuals in this context. The output summarizes the statistical significance of the terms in the forecasting model. Terms with *p*-values less than 0.05 are statistically significantly different from zero at the 95.0% confidence level. The *p*-value for the AR(x) or term is less than 0.05, so it is significantly different from 0. The *p*-value for the MA(x) term is less than 0.05, so it is significantly different from 0. When the trend is increasing, in order to obtain a linearity or central trend, the model also chooses q. The estimated standard deviation of the input white noise depends on the best model that was selected during the simulations performed.

According to the current literature, this would be the first study of such a manner. Therefore, the idea of a cluster of nations, and the rate of the spread between them is novel. This adds to the fact that this is the first study to address the situation of the most affected nations globally. In the present study the current situation of the COVID-19 pandemic in Ukraine, Romania, the Republic of Moldova, Serbia, Bulgaria, Hungary, USA, Brazil, and India was presented, and the ongoing trend and extent of the outbreak were estimated by the ARIMA model. According to our best of knowledge, this study is the first of its kind to implement ARIMA models to predict the prevalence of COVID-19 in such a manner.

In the current literature can be found limited data regarding the usage of ARIMA for the prediction of the COVID-19 course. Most reports evaluated the situation from western and southern Asia. Reports regarding the status of Europe are elusive for an unknown reason, and as a consequence, Europe gradually become the second mainland ([Table 5](#microorganisms-08-01158-t005){ref-type="table"}). It should be also mentioned that papers that have been subjected to the peer-review process were excluded.

Effective strategies are now all more imperative to control the spreading of COVID-19. Thus, estimating epidemiological trends is crucial for the allocations of medical resources and production activities.

Among the most effective alternatives that proved their efficacity is quarantine. Chintalapudi et al. \[[@B34-microorganisms-08-01158]\] have discussed the beneficial impact lockdown had within the Italian population in terms of transmissibility. A data-driven model analysis demonstrated a decrement up to 35% of total registered cases, concomitantly with an increase up to 66% of recovered cases after lockdown and self-isolation. The accuracy of these two parameters was 93.75 and 84.4%, respectively.

This tendency of regression proved to be true according to the results obtained by another group of authors. The accuracy of six performance metric models has been tested. Long short-term memory (LSTM) was found to be the most accurate during the study, perspective predictions within the next two weeks being made. Thus, is expected a slight decrease in the number of the total cumulative cases \[[@B35-microorganisms-08-01158]\].

These observations are strengthened by the results of Papastefanopoulos et al. \[[@B40-microorganisms-08-01158]\]. Six different time series approaches were also utilized to test the accuracy concerning the COVID-19 outbreak for the top ten most affected countries. Machine learning time series methods were efficiently used to estimate the percentage of the population that will be affected.

By using a stochastic modified SEIR model (susceptible--exposed--infectious--recovered) and due to lack of effective pharmaceutical interventions against SARS-CoV-2, López et al. \[[@B41-microorganisms-08-01158]\] concluded that social confinement should remain in place for the next two months. Behavior, awareness, and immunity decay is attributed to 99% of the current wave. The gradual incorporation of up to 50% of daily working proportion should be also considered.

It has been recently shown that Black and South Asian people are more prone to infection and subsequently death than the rest. Among the risk factors is age, being male, deprivation, diabetes, asthma, and numerous other medical conditions following the analysis of a cohort consisting of 17,278,392 UK individuals \[[@B42-microorganisms-08-01158]\].

If all these restrictions are not respected, humanity will face a second wave of infections much more severe than the previous one \[[@B37-microorganisms-08-01158]\] according to the latest statistics reported by WHO. Most certainly, governments' internal politics and capability in managing the current situation would be definitory during this temporary crisis \[[@B33-microorganisms-08-01158],[@B36-microorganisms-08-01158],[@B37-microorganisms-08-01158],[@B38-microorganisms-08-01158]\].

Assuming that 20% of the population of each country in the US will be infected, age-specific mortality pattern shown that counties will be probably heavily affected. These findings suggest the adequate allocation of the medical care resources per capita needed to outside communities to restrain the spread \[[@B43-microorganisms-08-01158]\].

Chakraborty et al. \[[@B32-microorganisms-08-01158]\] revealed that to people over the age of 65 should be paid more attention, which is why for them it is recommended intensive care and isolation. In addition, they suggests that the locktime period must be extended, in parallel with the arranging medical centers by increasing the number of beds.

Furthermore, Demongeot et al. \[[@B39-microorganisms-08-01158]\] have brought a new perspective regarding the important role temperature has on COVID-19 spreading, reflected by the total number of active cases. It seems that high temperature directly reduces contagion rates, but this does not mean seasonal temperature could not support the later reappearance following the usage of time series methods.

4. Conclusions {#sec4-microorganisms-08-01158}
==============

Forecasting the prevalence of a disease is crucial for health departments to create an optimum environment and conditions for patients. As has been presented throughout this manuscript, time series models play an important role in disease prediction. In this study, ARIMA time series models were successfully applied to estimate the overall prevalence of COVID-19 in nine countries, six of them being neighbors, while the other three are the most affected today.
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The (**a**,**b**) prevalence and (**a'**,**b'**) incidence of the COVID-19 within the established countries.
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The estimated Autocorrelation Function (ACF) and Partial Autocorrelation Function (PACF) graphs to predict the epidemiological trend of COVID-19 prevalence for Ukraine, Romania, the Republic of Moldova, Serbia, Bulgaria, Hungary, USA, Brazil, and India.
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![Time-series plots for the best ARIMA models.](microorganisms-08-01158-g003){#microorganisms-08-01158-f003}
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###### 

Descriptive statistics on the prevalence and incidence of coronavirus (COVID-19) in the established countries.

  ----------------------------------------- ------------- -------------- ------------- ------------- ------------- ------------- -------------- --------------
  **(a) Prevalence**                                                                                                                            
  **Continents**                            **Country**   **Mean**       **SE Mean**   **St. Dev**   **Minimum**   **Maximum**   **Skewness**   **Kurtosis**
  Central and Eastern Europe                Ukraine       17,545.34      1424.02       15793.16      1             52,043        0.5836         −0.8257
  Romania                                   13,958.65     837.07         9283.60       25            31,381        −0.0447       −1.1718        
  Republic of Moldova                       6341.02       516.67         5730.20       3             18,666        0.6936        −0.7263        
  Serbia                                    8159.77       468.22         5192.87       5             17,342        −0.3619       −1.1779        
  Bulgaria                                  2063.34       151.29         1677.90       4             6672          0.7943        −0.0721        
  Hungary                                   2618.48       138.75         1538.90       12            4220          −0.5892       −1.2725        
  South and North America, and South Asia   USA           1,242,336.35   80,297.41     890,541.35    696           3,038,325     0.1309         −1.1182
  Brazil                                    405,199.86    45,415.32      503,680.30    25            1,713,160     1.1576        0.0707         
  India                                     168,929.42    19,430.70      215,496.91    50            793,802       1.3365        0.7176         
  **(b) Incidence**                                                                                                                             
  **Continents**                            **Country**   **Mean**       **SE Mean**   **St. Dev**   **Minimum**   **Maximum**   **Skewness**   **Kurtosis**
  Central and Eastern Europe                Ukraine       423.10         25.90         287.33        0             1366          0.3931         −0.0052
  Romania                                   255.00        11.65          129.25        6             614           0.2298        −0.0560        
  Republic of Moldova                       151.74        10.03          111.27        0             478           0.7573        0.1075         
  Serbia                                    140.98        10.22          113.38        0             445           0.8188        −0.4346        
  Bulgaria                                  54.21         5.08           56.44         0             330           1.9756        4.8870         
  Hungary                                   34.23         3.09           34.36         0             210           1.6979        4.7398         
  South and North America, and South Asia   USA           24,697.99      1152.30       12,779.70     0             64,630        0.1378         0.8261
  Brazil                                    13,927.92     1307.41        14,499.97     0             54,771        0.8961        −0.3030        
  India                                     6453.31       644.93         7152.72       0             26,506        1.1402        0.2809         
  ----------------------------------------- ------------- -------------- ------------- ------------- ------------- ------------- -------------- --------------

microorganisms-08-01158-t002_Table 2

###### 

Comparison of tested Auto-Regressive Integrated Moving Average (ARIMA) models.

  Country               Model       RMSE      MAE       MAPE
  --------------------- ----------- --------- --------- ---------
  Ukraine               (1, 1, 0)   182.403   86.857    4.70244
  (0, 2, 0)             184.534     84.6694   4.75145   
  (3, 2, 0)             140.184     87.0874   4.86564   
  (3, 0, 0)             140.834     83.9104   5.02043   
  (2, 2, 0)             141.809     86.6818   5.08194   
  Romania               (3, 2, 2)   72.2811   54.8283   1.40016
  (1, 2, 3)             77.4246     57.1017   1.45906   
  (2, 2, 3)             74.5154     55.2809   1.48125   
  (3, 2, 3)             76.4564     56.4977   1.52647   
  (2, 2, 2)             78.7986     58.4657   1.53212   
  Republic of Moldova   (3, 2, 2)   61.1658   43.5817   2.76751
  (3, 2, 1)             60.7849     43.5131   2.77257   
  (2, 2, 1)             60.6597     43.5749   2.77809   
  (3, 2, 3)             61.6063     43.8593   2.84718   
  (2, 2, 3)             61.341      43.8542   2.85937   
  Serbia                (3, 1, 1)   43.0079   28.8086   2.16733
  (2, 1, 3)             43.0409     29.127    2.17147   
  (1, 1, 3)             42.8633     29.1174   2.17271   
  (3, 1, 0)             42.8659     28.847    2.17729   
  (2, 1, 2)             42.8686     29.1841   2.17814   
  Bulgaria              (1, 0, 3)   33.4732   23.1431   2.98154
  (2, 0, 2)             33.7635     23.0537   3.04647   
  (3, 0, 0)             33.5995     22.8279   3.08918   
  (3, 2, 0)             35.4064     23.7486   3.08997   
  (2, 2, 2)             78.7986     58.4657   1.53212   
  Hungary               (1, 2, 0)   23.0452   15.101    2.11239
  (0, 2, 3)             21.7985     13.6316   2.15973   
  (3, 2, 0)             22.6729     14.2714   2.16096   
  (3, 0, 0)             22.6563     14.488    2.16571   
  (2, 2, 3)             21.9873     13.6272   2.16876   
  USA                   (1, 1, 0)   6539.46   4673.82   3.21569
  (0, 2, 0)             6541.2      4710.64   3.2431    
  (3, 2, 1)             5818.42     4379.88   3.29508   
  (1, 2, 3)             5868.51     4434.36   3.29553   
  (2, 2, 3)             5888.31     4430.09   3.29999   
  Brazil                (0, 2, 1)   6134.91   3838.17   4.10596
  (2, 1, 0)             6493.37     3521.69   4.14127   
  (2, 2, 1)             5454.19     3118.73   4.15452   
  (1, 2, 0)             6515.51     3598.89   4.16568   
  (3, 2, 1)             5457.52     3082.2    4.1698    
  India                 (0, 2, 0)   642.607   416.132   2.78051
  (1, 1, 0)             574.812     376.235   2.7951    
  (2, 1, 0)             570.378     373.247   3.06874   
  (1, 1, 2)             524.071     358.294   3.19978   
  (3, 0, 1)             543.562     358.125   3.29689   

microorganisms-08-01158-t003_Table 3

###### 

Parameters of ARIMA models.

  Country and Best Model          Parameters         Estimate    Standard Error   *t*-Statistic   *p*-Value
  ------------------------------- ------------------ ----------- ---------------- --------------- -----------
  Ukraine (1, 1, 0)               AR(1)              0.943844    0.0325404        29.0053         0.000000
  Romania (3, 2, 2)               AR(3)              −0.410628   0.103264         −3.97648        0.000122
  MA(2)                           −0.758911          0.0916899   −8.27702         0.000000        
  Republic of Moldova (3, 2, 2)   AR(3)              −0.162489   10.6563          −0.0152482      0.987860
  MA(2)                           0.341459           26.5106     0.0128801        0.989746        
  Serbia (3, 1, 1)                AR(3)              0.241924    1.06252          0.227689        0.820282
  MA(1)                           −0.572339          2.98064     −0.192018        0.848058        
  Bulgaria (1, 0, 3)              AR(1)              1.02769     0.00227845       451.048         0.000000
  MA(3)                           −0.267346          0.0937488   −2.85172         0.005128        
  Hungary                         AR(1)              −0.401032   0.0836831        −4.79227        0.000005
  USA (1, 1, 0)                   AR(1)              0.99441     0.0217047        45.8154         0.000000
  Brazil (0, 2, 1)                MA(1)              0.758422    0.0565645        13.4081         0.000000
  India (0, 2, 0)                 no parameter (s)                                                

microorganisms-08-01158-t004_Table 4

###### 

Prediction of total confirmed cases of COVID-19 for the next fourteen days according to ARIMA models with 95% confidence interval.

  --------------------------- ---------------------------- --------------------------------------- ----------------- ------------ ----------------- ----------------- ----------------- ------------ ----------------- ----------------- -----------------
  **Ukraine ARIMA (1,1,0)**   **Romania ARIMA (3,2,2)**    **Republic of Moldova ARIMA (3,2,2)**                                                                                                                                         
                                                           **Lower 95%**                           **Upper 95%**                                    **Lower 95%**     **Upper 95%**                                    **Lower 95%**     **Upper 95%**
  **Period**                  **Forecast**                 **Limit**                               **Limit**         **Period**   **Forecast**      **Limit**         **Limit**         **Period**   **Forecast**      **Limit**         **Limit**
  11-7-20                     52,816.0                     52,454.9                                53,177.1          11-7-20      31,838.2          31,694.9          31,981.5          11-7-20      18,836.6          18,715.5          18,957.8
  12-7-20                     53,545.6                     52,756.2                                54,335.0          12-7-20      32,261.6          32,023.7          32,499.5          12-7-20      19,037.2          18,806.5          19,268.0
  13-7-20                     54,234.2                     52,941.6                                55,526.9          13-7-20      32,719.8          32,386.2          33,053.5          13-7-20      19,259.3          18,940.0          19,578.5
  14-7-20                     54,884.2                     53,031.4                                56,736.9          14-7-20      33,267.3          32,849.6          33,685.1          14-7-20      19,478.9          19,081.4          19,876.5
  15-7-20                     55,497.6                     53,040.6                                57,954.7          15-7-20      33,872.9          33,362.9          34,383.0          15-7-20      19,691.4          19,211.9          20,170.8
  16-7-20                     56,076.7                     52,980.2                                59,173.1          16-7-20      34,469.6          33,845.7          35,093.5          16-7-20      19,901.5          19,332.3          20,470.6
  17-7-20                     56,623.2                     52,859.4                                60,386.9          17-7-20      35,003.7          34,237.5          35,769.8          17-7-20      20,113.1          19,448.2          20,778.0
  18-7-20                     57,139.0                     52,685.5                                61,592.4          18-7-20      35,477.4          34,549.7          36,405.1          18-7-20      20,326.1          19,561.3          21,090.8
  19-7-20                     57,625.8                     52,464.9                                62,786.7          19-7-20      35,938.6          34,844.5          37,032.8          19-7-20      20,539.0          19,670.8          21,407.3
  20-7-20                     58,085.3                     52,202.9                                63,967.7          20-7-20      36,438.8          35,182.0          37,695.7          20-7-20      20,751.6          19,775.9          21,727.3
  21-7-20                     58,519.0                     51,904.2                                65,133.8          21-7-20      36,992.8          35,575.4          38,410.2          21-7-20      20,964.0          19,876.7          22,051.2
  22-7-20                     58,928.3                     51,573.0                                66,283.7          22-7-20      37,572.2          35,988.4          39,156.0          22-7-20      21,176.4          19,973.7          22,379.1
  23-7-20                     59,314.7                     51,212.8                                67,416.6          23-7-20      38,132.9          36,369.6          39,896.1          23-7-20      21,389.0          20,067.1          22,710.8
  24-7-20                     59,679.3                     50,826.8                                68,531.9          24-7-20      38,650.7          36,693.2          40,608.1          24-7-20      21,601.5          20,156.8          23,046.2
  **Serbia ARIMA (3,1,1)**    **Bulgaria ARIMA (1,0,3)**   **Hungary ARIMA (1,2,0)**                                                                                                                                                     
                                                           **Lower 95%**                           **Upper 95%**                                    **Lower 95%**     **Upper 95%**                                    **Lower 95%**     **Upper 95%**
  **Period**                  **Forecast**                 **Limit**                               **Limit**         **Period**   **Forecast**      **Limit**         **Limit**         **Period**   **Forecast**      **Limit**         **Limit**
  11-7-20                     17,639.6                     17,554.5                                17,724.8          11-7-20      6931.5            6865.22           6997.79           11-7-20      4225.99           4180.36           4271.62
  12-7-20                     17,927.0                     17,765.1                                18,088.8          12-7-20      7179.18           7065.11           7293.25           12-7-20      4233.59           4147.54           4319.64
  13-7-20                     18,214.2                     17,956.8                                18,471.6          13-7-20      7405.16           7239.7            7570.63           13-7-20      4240.54           4102.74           4378.34
  14-7-20                     18,501.8                     18,135.5                                18,868.0          14-7-20      7610.22           7392.89           7827.55           14-7-20      4247.75           4051.78           4443.73
  15-7-20                     18,786.8                     18,300.4                                19,273.2          15-7-20      7820.95           7559.81           8082.1            15-7-20      4254.86           3993.94           4515.78
  16-7-20                     19,072.0                     18,454.5                                19,689.5          16-7-20      8037.53           7736.95           8338.1            16-7-20      4262.01           3930.38           4593.64
  17-7-20                     19,355.4                     18,597.4                                20,113.5          17-7-20      8260.09           7922.85           8597.34           17-7-20      4269.14           3861.35           4676.93
  18-7-20                     19,638.3                     18,730.5                                20,546.1          18-7-20      8488.83           8116.76           8860.89           18-7-20      4276.28           3787.29           4765.27
  19-7-20                     19,919.9                     18,854.1                                20,985.8          19-7-20      8723.89           8318.28           9129.5            19-7-20      4283.42           3708.46           4858.38
  20-7-20                     20,200.7                     18,968.8                                21,432.6          20-7-20      8965.47           8527.2            9403.73           20-7-20      4290.56           3625.12           4955.99
  21-7-20                     20,480.4                     19,075.0                                21,885.8          21-7-20      9213.73           8743.44           9684.02           21-7-20      4297.69           3537.49           5057.89
  22-7-20                     20,759.2                     19,173.2                                22,345.2          22-7-20      9468.87           8966.96           9970.78           22-7-20      4304.83           3445.76           5163.91
  23-7-20                     21,036.9                     19,263.5                                22,810.3          23-7-20      9731.07           9197.81           10,264.3          23-7-20      4311.97           3350.08           5273.86
  24-7-20                     21,313.7                     19,346.4                                23,281.0          24-7-20      10,000.5          9436.04           10,565.0          24-7-20      4319.11           3250.6            5387.62
  **USA ARIMA (1,1,0)**       **Brazil ARIMA (0,2,1)**     **India ARIMA (0,2,0)**                                                                                                                                                       
                                                           **Lower 95%**                           **Upper 95%**                                    **Lower 95%**     **Upper 95%**                                    **Lower 95%**     **Upper 95%**
  **Period**                  **Forecast**                 **Limit**                               **Limit**         **Period**   **Forecast**      **Limit**         **Limit**         **Period**   **Forecast**      **Limit**         **Limit**
  11-7-20                     3.10259 × 10^6^              3.08965 × 10^6^                         3.11554 × 10^6^   11-7-20      1.75087 × 10^6^   1.73873 × 10^6^   1.76302 × 10^6^   11-7-20      820,308           819,036           821,580
  12-7-20                     3.1665 × 10^6^               3.13762 × 10^6^                         3.19539 × 10^6^   12-7-20      1.78858 × 10^6^   1.76922 × 10^6^   1.80795 × 10^6^   12-7-20      846,814           843,969           849,659
  13-7-20                     3.23006 × 10^6^              3.18183 × 10^6^                         3.27828 × 10^6^   13-7-20      1.8263 × 10^6^    1.79985 × 10^6^   1.85275 × 10^6^   13-7-20      873,320           868,560           878,080
  14-7-20                     3.29325 × 10^6^              3.2228 × 10^6^                          3.3637 × 10^6^    14-7-20      1.86401 × 10^6^   1.83027 × 10^6^   1.89775 × 10^6^   14-7-20      899,826           892,858           906,794
  15-7-20                     3.3561 × 10^6^               3.26091 × 10^6^                         3.45129 × 10^6^   15-7-20      1.90172 × 10^6^   1.86038 × 10^6^   1.94306 × 10^6^   15-7-20      926,332           916,897           935,767
  16-7-20                     3.41859 × 10^6^              3.2964 × 10^6^                          3.54077 × 10^6^   16-7-20      1.93943 × 10^6^   1.89016 × 10^6^   1.98871 × 10^6^   16-7-20      952,838           940,702           964,974
  17-7-20                     3.48073 × 10^6^              3.3295 × 10^6^                          3.63196 × 10^6^   17-7-20      1.97714 × 10^6^   1.91958 × 10^6^   2.03471 × 10^6^   17-7-20      979,344           964,291           994,397
  18-7-20                     3.54253 × 10^6^              3.36035 × 10^6^                         3.7247 × 10^6^    18-7-20      2.01486 × 10^6^   1.94866 × 10^6^   2.08105 × 10^6^   18-7-20      1.00585 × 10^6^   987,679           1.02402 × 10^6^
  19-7-20                     3.60398 × 10^6^              3.3891 × 10^6^                          3.81885 × 10^6^   19-7-20      2.05257 × 10^6^   1.9774 × 10^6^    2.12774 × 10^6^   19-7-20      1.03236 × 10^6^   1.01088 × 10^6^   1.05383 × 10^6^
  20-7-20                     3.66508 × 10^6^              3.41586 × 10^6^                         3.91431 × 10^6^   20-7-20      2.09028 × 10^6^   2.0058 × 10^6^    2.17476 × 10^6^   20-7-20      1.05886 × 10^6^   1.0339 × 10^6^    1.08382 × 10^6^
  21-7-20                     3.72585 × 10^6^              3.44073 × 10^6^                         4.01097 × 10^6^   21-7-20      2.12799 × 10^6^   2.03387 × 10^6^   2.22211 × 10^6^   21-7-20      1.08537 × 10^6^   1.05675 × 10^6^   1.11399 × 10^6^
  22-7-20                     3.78627 × 10^6^              3.46379 × 10^6^                         4.10876 × 10^6^   22-7-20      2.16571 × 10^6^   2.06163 × 10^6^   2.26978 × 10^6^   22-7-20      1.11187 × 10^6^   1.07944 × 10^6^   1.14431 × 10^6^
  23-7-20                     3.84636 × 10^6^              3.48513 × 10^6^                         4.2076 × 10^6^    23-7-20      2.20342 × 10^6^   2.08907 × 10^6^   2.31776 × 10^6^   23-7-20      1.13838 × 10^6^   1.10197 × 10^6^   1.17479 × 10^6^
  24-7-20                     3.90611 × 10^6^              3.5048 × 10^6^                          4.30743 × 10^6^   24-7-20      2.24113 × 10^6^   2.11621 × 10^6^   2.36605 × 10^6^   24-7-20      1.16489 × 10^6^   1.12435 × 10^6^   1.20542 × 10^6^
  --------------------------- ---------------------------- --------------------------------------- ----------------- ------------ ----------------- ----------------- ----------------- ------------ ----------------- ----------------- -----------------
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###### 

Studies conducted to predict COVID-19 spreading in which were used distinct statistical approaches.

  Disease              Method(s)                                 Reference
  -------------------- ----------------------------------------- -----------------------------------------
  COVID-19             Hybrid ARIMA-WBF                          \[[@B32-microorganisms-08-01158]\] ^\$^
  SutteARIMA           \[[@B33-microorganisms-08-01158]\] \*     
  Seasonal ARIMA       \[[@B34-microorganisms-08-01158]\] \*     
  ARIMA                \[[@B35-microorganisms-08-01158]\] \*     
  NARNN                                                          
  LSTM                                                           
  ARIMA                \[[@B36-microorganisms-08-01158]\] \*     
  ARIMA                \[[@B37-microorganisms-08-01158]\] ^\$^   
  ARIMA                \[[@B38-microorganisms-08-01158]\] ^\$^   
  ARIMA                \[[@B39-microorganisms-08-01158]\] ^\$^   
  ARIMA                \[[@B40-microorganisms-08-01158]\] ^\$^   
  HWAAS                                                          
  TBAT                                                           
  Facebook's Prophet                                             
  DeepAR                                                         
  N-Beats                                                        

^\$^ European and non-European countries are included; \* strictly European countries included.
